Anti-myogenic and profibrotic effect of serum from patients affected by muscular laminopathies.
Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases · 01.06.2025 · 44 (2) · 73-76
DOI: 10.36185/2532-1900-1126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, erschienen am 01.06.2025. Verfasst von Elisa Schena und 4 weiteren Autor:innen. Beteiligte Einrichtung: CNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Muscular Dystrophy, Emery-Dreifuss, Lamin Type A, Muscle Development, Myoblasts. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Emery-Dreifuss Muscular Dystrophy type 2 (EDMD2) and LMNA-related congenital muscular dystrophy (L-CMD) are caused by mutations in LMNA gene. Both pathologies are characterized by joint contractures, muscle weakness and wasting and cardiac involvement. In the last few years, circulating factors have been proposed to play a critical role in the pathogenesis of these diseases. Based on this consideration, we studied the effect of laminopathic serum on the myogenic differentiation in healthy human myoblasts in culture. We observed impaired myogenesis and increased fibrosis in myoblast cultures conditioned with laminopathic serum and a dramatic increase in the level of profibrotic and proinflammatory cytokines in the cell culture supernatants. These results strongly support the pathogenic role of circulating factors in muscular laminopathies and pave the way to a possible therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza" Unit of Bologna, Bologna, Italy.
- IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
- IRCCS Institute of Neurological Sciences of Bologna, Bologna, Italy.
- Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta" Milan, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Zitieren
APA
Schena, E., Pini, A., Cavalcante, P., Siciliano, G., & Ricci, G. (2025). Anti-myogenic and profibrotic effect of serum from patients affected by muscular laminopathies. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases, 44(2), 73-76. https://doi.org/10.36185/2532-1900-1126
Vancouver
Schena E, Pini A, Cavalcante P, Siciliano G, Ricci G. Anti-myogenic and profibrotic effect of serum from patients affected by muscular laminopathies. Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases. 2025;44(2):73-76. doi:10.36185/2532-1900-1126
BibTeX
@article{Schena2025,
author = {Schena, Elisa and Pini, Antonella and Cavalcante, Paola and Siciliano, Gabriele and Ricci, Giulia},
title = {Anti-myogenic and profibrotic effect of serum from patients affected by muscular laminopathies},
journal = {Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology / edited by the Gaetano Conte Academy for the study of striated muscle diseases},
year = {2025},
volume = {44},
number = {2},
pages = {73--76},
doi = {10.36185/2532-1900-1126}
}
EUVIMED